Does continuous positive airways pressure treatment improve clinical depression in obstructive sleep apnea? A randomized wait-list controlled study.
clinical trial
depression
sleep disorder
treatment resistance
Journal
Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
12
11
2020
received:
17
04
2020
accepted:
14
11
2020
pubmed:
29
12
2020
medline:
1
6
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that is associated with a range of adverse daytime sequelae, including significantly higher rates of clinical depression than is seen in the general community. Improvements in depressive symptoms occur after treatment of the primary sleep disorder, suggesting that comorbid depression might be an intrinsic feature of OSA. However, there are limited data on whether treatment for OSA in patients diagnosed with clinical depression improves mood symptoms meaningfully enough to lead to the remission of the psychiatric diagnosis. N = 121 untreated OSA patients were randomized to either continuous positive airway pressure (CPAP) treatment or waitlist control, and depressive symptoms, sleepiness and clinical depression (using a structured clinical interview) were assessed at baseline and 4 months. Linear and logistic regression analyses were conducted, controlling for baseline scores, stratification factors and antidepressant use. Depressive symptoms (odds ratio [OR] = -4.19; 95% confidence interval [CI] = -7.25, -1.13; p = .008) and sleepiness (OR = -4.71; 95% CI = -6.26, -3.17; p < .001) were significantly lower at 4 months in the CPAP group compared to waitlist. At 4 months, there was a significant reduction in the proportion of participants in the CPAP group meeting criteria for clinical depression, compared to the waitlist controls (OR = 0.06, 95% CI = 0.01, 0.37; p = .002). Treatment of OSA may be a novel approach for the management and treatment of clinical depression in those with comorbid sleep disordered breathing. Larger trials of individuals with clinical depression and comorbid OSA are needed.
Sections du résumé
BACKGROUND
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that is associated with a range of adverse daytime sequelae, including significantly higher rates of clinical depression than is seen in the general community. Improvements in depressive symptoms occur after treatment of the primary sleep disorder, suggesting that comorbid depression might be an intrinsic feature of OSA. However, there are limited data on whether treatment for OSA in patients diagnosed with clinical depression improves mood symptoms meaningfully enough to lead to the remission of the psychiatric diagnosis.
METHODS
N = 121 untreated OSA patients were randomized to either continuous positive airway pressure (CPAP) treatment or waitlist control, and depressive symptoms, sleepiness and clinical depression (using a structured clinical interview) were assessed at baseline and 4 months. Linear and logistic regression analyses were conducted, controlling for baseline scores, stratification factors and antidepressant use.
RESULTS
Depressive symptoms (odds ratio [OR] = -4.19; 95% confidence interval [CI] = -7.25, -1.13; p = .008) and sleepiness (OR = -4.71; 95% CI = -6.26, -3.17; p < .001) were significantly lower at 4 months in the CPAP group compared to waitlist. At 4 months, there was a significant reduction in the proportion of participants in the CPAP group meeting criteria for clinical depression, compared to the waitlist controls (OR = 0.06, 95% CI = 0.01, 0.37; p = .002).
CONCLUSION
Treatment of OSA may be a novel approach for the management and treatment of clinical depression in those with comorbid sleep disordered breathing. Larger trials of individuals with clinical depression and comorbid OSA are needed.
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
498-507Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
American Psychiatric Association. (1994). Diagnostic criteria from DSM-IV: Amer Psychiatric Pub Inc.
Balcan, B., Thunstrom, E., Strollo, P. J., Jr., & Peker, Y. (2019). Continuous positive airway Pressure treatment and depression in adults with coronary artery disease and nonsleepy obstructive sleep apnea. A secondary analysis of the RICCADSA trial. Annals of the American Thoracic Society, 16(1), 62-70. https://doi.org/10.1513/AnnalsATS.201803-174OC
Bardwell, W. A., Ancoli-Israel, S., & Dimsdale, J. E. (2007). Comparison of the effects of depressive symptoms and apnea severity on fatigue in patients with obstructive sleep apnea: A replication study. Journal of Affective Disorders, 97(1-3), 181-186. https://doi.org/10.1016/j.jad.2006.06.013
Barnes, M., Houston, D., Worsnop, C. J., Neill, A. M., Mykytyn, I. J., Kay, A., TRINDER, J., SAUNDERS, N. A., McEVOY, R. D., & PIERCE, R. J. (2002). A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. AJRCCM, 165(6), 773-780.
Barnes, M., McEvoy, R. D., Banks, S., Tarquinio, N., Murray, C. G., Vowles, N., & Pierce, R. J. (2004). Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 170(6), 656-664.
Bartlett, D. J., Rae, C., Thompson, C. H., Byth, K., Joffe, D. A., Enright, T., & Grunstein, R. R. (2004). Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apnea. Sleep Medicine, 5(6), 593-596.
Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pépin, J. L., Peppard, P. E., Sinha, S., Tufik, S., Valentine, K., & Malhotra, A. (2019). An estimate of the global prevalence and burden of obstructive sleep apnoea. Lancet Respiratory Medicine, 7, 687-698. https://doi.org/10.1016/S2213-2600(19)30198-5
Borak, J., Cieslicki, J., Koziej, M., Matuszewski, A., & Zielinski, J. (1996). Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. Journal of Sleep Research, 5(2), 123-127. https://doi.org/10.1046/j.1365-2869.1996.d01-60.x
Bucks, R. S., Nanthakumar, S., Starkstein, S. S., Hillman, D. R., James, A., McArdle, N., Hatch, K., & Skinner, T. C. (2018). Discerning depressive symptoms in patients with obstructive sleep apnea: the effect of continuous positive airway pressure therapy on Hamilton Depression Rating Scale symptoms. Sleep, 41(12), zsy178.
Ciftci, T. U., Kokturk, O., Bukan, N., & Bilgihan, A. (2004). The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine, 28(2), 87-91.
Crawford, M. R., Bartlett, D. J., Coughlin, S. R., Phillips, C. L., Neill, A. M., Espie, C. A., Dungan, G. C., Wilding, J. P. H., Calverley, P. M. A., Grunstein, R. R., & Marshall, N. S. (2012). The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea: real effects or expectation of benefit? Thorax, 67(10), 920-924.
Cross, R. L., Kumar, R., Macey, P. M., Doering, L. V., Alger, J. R., Yan-Go, F. L., & Harper, R. M. (2008). Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep, 31(8), 1103.
Dahlof, P., Ejnell, H., Hallstrom, T., & Hedner, J. (2000). Surgical treatment of the sleep apnea syndrome reduces associated major depression. International journal of behavioral medicine, 7(1), 73-88.
Deloitte Access Economics. (2011). Re-awakening Australia: The economic cost of sleep disorders in Australia, 2010. Sleep Health Foundation.
Eldahdouh, S. S., El-Habashy, M. M., & Elbahy, M. S. (2014). Effect of CPAP on depressive symptoms in OSA. Egyptian Journal of Chest Diseases and Tuberculosis, 63(2), 389-393. https://doi.org/10.1016/j.ejcdt.2013.11.009
El-Sherbini, A. M., Bediwy, A. S., & El-Mitwalli, A. (2011). Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment. Neuropsychiatric Disease and Treatment, 7, 715-721.
Engleman, H., Kingshott, R. N., Wraith, P. K., Mackay, T. W., Deary, I. J., & Douglas, N. J. (1999). Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. AJRCCM, 159(2), 461-467.
Ferrari, A., Somerville, A., Baxter, A., Norman, R., Patten, S., Vos, T., & Whiteford, H. (2013). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471-481.
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1994). Structured clinical interview for Axis I DSM IV disorders. New York State Psychiatric Institute.
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008). A meta-analytic study of changes in brain activation in depression. Human Brain Mapping, 29(6), 683-695.
Gagnadoux, F., Le Vaillant, M., Goupil, F., Pigeanne, T., Chollet, S., Masson, P., Bizieux-Thaminy, A., Humeau, M. P., & Meslier, N. (2014). Depressive symptoms before and after long-term CPAP therapy in patients with sleep apnea. Chest, 145(5), 1025-1031.
Habukawa, M., Uchimura, N., Kakuma, T., Yamamoto, K., Ogi, K., Hiejima, H., Tomimatsu, K., & Matsuyama, S. (2010). Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms. Sleep Medicine, 11(6), 552-557. https://doi.org/10.1016/j.sleep.2010.02.007
Haensel, A., Norman, D., Natarajan, L., Bardwell, W. A., Ancoli-Israel, S., & Dimsdale, J. E. (2007). Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: A double-blind trial. Sleep & Breathing, 11(4), 239-244. https://doi.org/10.1007/s11325-007-0115-0
Harris, M., Glozier, N., Ratnavadivel, R., & Grunstein, R. R. (2009). Obstructive sleep apnea and depression. Sleep Medicine Reviews, 13(6), 437-444.
Henke, K. G., Grady, J. J., & Kuna, S. T. (2001). Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome: A randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine, 163(4), 911-917.
Jackson, M. L., McEvoy, R. D., Banks, S., & Barnes, M. (2018). Neurobehavioral impairment and CPAP treatment response in mild-moderate obstructive sleep apnea. Journal of Clinical Sleep Medicine, 14(01), 47-56.
Jackson, M. L., Tolson, J., Bartlett, D., Berlowitz, D. J., Varma, P., & Barnes, M. (2019). Clinical depression in untreated Obstructive Sleep Apnea: examining predictors and a meta-analysis of prevalence rates. Sleep Medicine, 62, 22-28. https://doi.org/10.1016/j.sleep.2019.03.011
Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep, 14(6), 540-545.
Kornstein, S. G., & Schneider, R. K. (2001). Clinical features of treatment-resistant depression. Journal of Clinical Psychiatry, 62(Suppl 16), 18-25.
Kritikou, I., Basta, M., Vgontzas, A. N., Pejovic, S., Fernandez-Mendoza, J., Liao, D., Bixler, E. O., Gaines, J., & Chrousos, G. P. (2016). Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: Effects of continuous positive airway pressure. European Respiratory Journal, 47(2), 531-540.
Kylstra, W. A., Aaronson, J. A., Hofman, W. F., & Schmand, B. A. (2013). Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: A meta-analysis. Sleep medicine reviews, 17(5), 341-347. https://doi.org/10.1016/j.smrv.2012.09.002
Law, M., Naughton, M., Ho, S., Roebuck, T., & Dabscheck, E. (2014). Depression may reduce adherence during CPAP titration trial. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 10(2), 163-169. https://doi.org/10.5664/jcsm.3444
Lee, I. S., Bardwell, W., Ancoli-Israel, S., Loredo, J. S., & Dimsdale, J. E. (2012). Effect of three weeks of continuous positive airway pressure treatment on mood in patients with obstructive sleep apnoea: A randomized placebo-controlled study. Sleep Medicine, 13(2), 161-166. https://doi.org/10.1016/j.sleep.2011.09.005
McCall, W. V., Benca, R. M., Rumble, M. E., Case, D., Rosenquist, P. B., & Krystal, A. D. (2019). Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder. Journal of Psychiatric Research, 116, 147-150.
Means, M. K., Lichstein, K. L., Edinger, J. D., Taylor, D. J., Durrence, H. H., Husain, A. M., Aguillard, R. N., & Radtke, R. A. (2003). Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep & Breathing, 7(1), 31-42.
Morrell, M. J., Jackson, M. L., Twigg, G. L., Ghiassi, R., McRobbie, D. W., Quest, R. A., Pardoe, H., Pell, G. S., Abbott, D. F., Rochford, P. D., Jackson, G. D., Pierce, R. J., O'Donoghue, F. J., & Corfield, D. R. (2010). Changes in brain morphology in patients with obstructive sleep apnoea. Thorax, 65(10), 908-914. https://doi.org/10.1136/thx.2009.126730
Munoz, A., Mayoralas, L., Barbe, F., Pericas, J., & Agusti, A. (2000). Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. European Respiratory Journal, 15(4), 676-681.
Murphy, J. A., Sarris, J., & Byrne, G. J. (2017). A review of the conceptualisation and risk factors associated with treatment-resistant depression. Depression Research and Treatment, 2017, 10. https://doi.org/10.1155/2017/4176825
Nanthakumar, S., Bucks, R. S., & Skinner, T. C. (2015). Are we overestimating the prevalence of depression in chronic illness using questionnaires? Meta-analytic evidence in obstructive sleep apnoea.
Nikolakaros, G., Virtanen, I., Markkula, J., Vahlberg, T., & Saaresranta, T. (2015). Obstructive sleep apnea in psychiatric outpatients. A clinic-based study. Journal of Psychiatric Research, 69, 126-134. https://doi.org/10.1016/j.jpsychires.2015.07.028
O'Donoghue, F. J., Wellard, R. M., Rochford, P. D., Dawson, A., Barnes, M., Ruehland, W. R., Jackson, M. L., Howard, M. E., Pierce, R. J., & Jackson, G. D. (2012). Magnetic resonance spectroscopy and neurocognitive dysfunction in obstructive sleep apnea before and after CPAP treatment. Sleep, 35(1), 41-48.
Ohayon, M. M. (2003). The effects of breathing-related sleep disorders on mood disturbances in the general population. Journal of Clinical Psychiatry, 64(10), 1195-1200.
Povitz, M., Bolo, C. E., Heitman, S. J., Tsai, W. H., Wang, J., & James, M. T. (2014). Effect of treatment of obstructive sleep apnea on depressive symptoms: systematic review and meta-analysis. PLOS Medicine, 11(11), e1001762. https://doi.org/10.1371/journal.pmed.1001762
Radloff, L. S. (1977). The CES-D scale. Applied Psychological Measurement, 1(3), 385-401. https://doi.org/10.1177/014662167700100306
Relia, S., Thompson, N. R., Mehra, R., Moul, D., Katzan, I., Foldvary-Schaefer, N., & Walia, H. K. (2018). Depression score changes in response to sleep disordered breathing treatment with positive airway pressure in a large clinic-based cohort. Sleep and Breathing, 22(1), 195-203.
Robillard, R., Chase, T., Courtney, D., Ward, M., De Koninck, J., & Lee, E. K. (2019). Sleep-related breathing disturbances in adolescents with treatment resistant depression. Sleep Medicine, 56, 47-51. https://doi.org/10.1016/j.sleep.2018.12.010
Rosenthal, L. D., & Dolan, D. C. (2008). The Epworth sleepiness scale in the identification of obstructive sleep apnea. The Journal of Nervous and Mental Disease, 196(5), 429-431.
Saunamäki, T., & Jehkonen, M. (2007). Depression and anxiety in obstructive sleep apnea syndrome: A review. Acta Neurologica Scandinavica, 116(5), 277-288.
Schwartz, D. J., & Karatinos, G. (2007). For individuals with obstructive sleep apnea, institution of CPAP therapy is associated with an amelioration of symptoms of depression which is sustained long term. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 3(6), 631-635.
Schwartz, D. J., Kohler, W. C., & Karatinos, G. (2005). Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest, 128(3), 1304-1309.
Stranks, E. K., & Crowe, S. F. (2016). The cognitive effects of obstructive sleep apnea: An updated meta-analysis. Archives of Clinical Neuropsychology, 31(2), 186-193. https://doi.org/10.1093/arclin/acv087
Twigg, G. L., Papaioannou, I., Jackson, M., Ghiassi, R., Shaikh, Z., Jaye, J., Graham, K. S., Simonds, A. K., & Morrell, M. J. (2010). Obstructive sleep apnea syndrome is associated with deficits in verbal but not visual memory. AJRCCM, 182(1), 98-103. https://doi.org/10.1164/rccm.200901-0065OC
van Agtmaal, M. J., Houben, A. J., Pouwer, F., Stehouwer, C. D., & Schram, M. T. (2017). Association of microvascular dysfunction with late-life depression: A systematic review and meta-analysis. Jama Psychiatry, 74(7), 729-739.
van Buuren, S., Brand, J. P., Groothuis-Oudshoorn, C. G., & Rubin, D. B. (2006). Fully conditional specification in multivariate imputation. Journal of Statistical and Computational Simulation. 2006, 76, 1049-1064. https://doi.org/10.1080/10629360600810434.
van Hecke, O., Hocking, L. J., Torrance, N., Campbell, A., Padmanabhan, S., Porteous, D. J., McIntosh, A. M., Burri, A. V., Tanaka, H., Williams, F. M. K., & Smith, B. H. (2017). Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study. PLOS One, 12(2), e0170653.
Wallace, A., & Bucks, R. (2013). Memory and obstructive sleep apnea: A meta-analysis. Sleep, 36(2), 203-220.
White, J., Cates, C., & Wright, J. (2002). Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database of System Review. (2), CD001106.
Waterman, L., Stahl, S. T., Buysse, D. J., Lenze, E. J., Blumberger, D., Mulsant, B., Butters, M., Gebara, M. A., Reynolds, C. F., & Karp, J. F. (2016). Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression. Depression and Anxiety, 33(12), 1107-1113.
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002). Epidemiology of obstructive sleep apnea: A population health perspective. American Journal of Respiratory and Critical Care Medicine, 165(9), 1217-1239. https://doi.org/10.1164/rccm.2109080
Yu, B. H., Ancoli-Israel, S., & Dimsdale, J. E. (1999). Effect of CPAP treatment on mood states in patients with sleep apnea. Journal of Psychiatric Research, 33(5), 427-432.